Form4.ai tracks every SEC insider trade in real time. See every AMRX insider filing with a free account — no card.
See every AMRX insider filing — free account, no card.
Free accountAmneal Pharmaceuticals, Inc. (AMRX) has 11 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $6.3M. Most recent filing: Sept. 21, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 21, 2026 SEC filing | BUCHI J KEVIN Director | Gift | — | — |
| Sep 14, 2026 SEC filing | BUCHI J KEVIN Director | Option exercise | $295,430 | — |
| Sep 2, 2026 SEC filing | BOYER ANDREW S Executive Vice President | Gift | — | — |
Create a free account to see all 11 AMRX filings from the last 90 days. No card needed.
Create free accountWant AMRX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.